BETA DRUGS
|
BETA DRUGS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹10 Cr | ₹9.61 Cr | ₹9.61 Cr | ₹9.61 Cr | ₹9.61 Cr |
| Equity - Authorised | ₹11 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹10.00 Cr |
| Equity - Issued | ₹10 Cr | ₹9.61 Cr | ₹9.61 Cr | ₹9.61 Cr | ₹9.61 Cr |
| Equity Paid Up | ₹10 Cr | ₹9.61 Cr | ₹9.61 Cr | ₹9.61 Cr | ₹9.61 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹187 Cr | ₹148 Cr | ₹113 Cr | ₹83 Cr | ₹59 Cr |
| Securities Premium | ₹23 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹164 Cr | ₹124 Cr | ₹89 Cr | ₹59 Cr | ₹35 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | - | - | - | - | - |
| Reserve excluding Revaluation Reserve | ₹187 Cr | ₹148 Cr | ₹113 Cr | ₹83 Cr | ₹59 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹197 Cr | ₹157 Cr | ₹123 Cr | ₹92 Cr | ₹69 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹9.99 Cr | ₹6.04 Cr | ₹6.97 Cr | ₹12 Cr | ₹11 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹7.60 Cr | ₹2.62 Cr | ₹3.85 Cr | ₹6.27 Cr | ₹5.85 Cr |
| Term Loans - Institutions | ₹3.46 Cr | ₹4.18 Cr | ₹3.23 Cr | ₹5.12 Cr | ₹5.18 Cr |
| Other Secured | ₹-1.06 Cr | ₹-0.76 Cr | ₹-0.11 Cr | ₹0.44 Cr | ₹0.09 Cr |
| Unsecured Loans | ₹117 Cr | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | ₹117 Cr | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-1.83 Cr | ₹-1.41 Cr | ₹-1.20 Cr | ₹-0.68 Cr | ₹-0.65 Cr |
| Deferred Tax Assets | ₹1.83 Cr | ₹1.42 Cr | ₹1.20 Cr | ₹0.81 Cr | ₹0.66 Cr |
| Deferred Tax Liability | - | ₹0.00 Cr | - | ₹0.13 Cr | ₹0.01 Cr |
| Other Long Term Liabilities | ₹6.86 Cr | ₹4.09 Cr | ₹3.72 Cr | ₹3.24 Cr | ₹3.33 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹2.56 Cr | ₹2.18 Cr | ₹1.83 Cr | ₹1.48 Cr | ₹1.14 Cr |
| Total Non-Current Liabilities | ₹135 Cr | ₹11 Cr | ₹11 Cr | ₹16 Cr | ₹15 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹71 Cr | ₹59 Cr | ₹40 Cr | ₹32 Cr | ₹20 Cr |
| Sundry Creditors | ₹71 Cr | ₹59 Cr | ₹40 Cr | ₹32 Cr | ₹20 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹21 Cr | ₹18 Cr | ₹9.54 Cr | ₹8.63 Cr | ₹7.85 Cr |
| Bank Overdraft / Short term credit | - | ₹5.24 Cr | ₹0.21 Cr | ₹0.29 Cr | ₹1.44 Cr |
| Advances received from customers | ₹11 Cr | ₹1.76 Cr | ₹0.21 Cr | ₹0.46 Cr | ₹1.06 Cr |
| Interest Accrued But Not Due | ₹0.01 Cr | ₹0.07 Cr | ₹0.08 Cr | ₹0.09 Cr | ₹0.10 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹11 Cr | ₹11 Cr | ₹9.05 Cr | ₹7.79 Cr | ₹5.26 Cr |
| Short Term Borrowings | ₹5.71 Cr | ₹4.96 Cr | ₹9.07 Cr | ₹4.75 Cr | ₹3.54 Cr |
| Secured ST Loans repayable on Demands | ₹5.71 Cr | ₹4.96 Cr | ₹9.07 Cr | ₹4.75 Cr | ₹3.54 Cr |
| Working Capital Loans- Sec | ₹5.71 Cr | ₹4.96 Cr | ₹9.07 Cr | ₹4.75 Cr | ₹3.54 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-5.71 Cr | ₹-4.96 Cr | ₹-9.07 Cr | ₹-4.75 Cr | ₹-3.54 Cr |
| Short Term Provisions | ₹15 Cr | ₹13 Cr | ₹11 Cr | ₹9.51 Cr | ₹4.71 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹15 Cr | ₹13 Cr | ₹11 Cr | ₹9.51 Cr | ₹4.71 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | - | - | - | - | - |
| Total Current Liabilities | ₹113 Cr | ₹94 Cr | ₹70 Cr | ₹55 Cr | ₹37 Cr |
| Total Liabilities | ₹445 Cr | ₹262 Cr | ₹204 Cr | ₹163 Cr | ₹120 Cr |
| ASSETS | |||||
| Gross Block | ₹146 Cr | ₹109 Cr | ₹99 Cr | ₹82 Cr | ₹61 Cr |
| Less: Accumulated Depreciation | ₹57 Cr | ₹45 Cr | ₹37 Cr | ₹27 Cr | ₹21 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹89 Cr | ₹65 Cr | ₹63 Cr | ₹55 Cr | ₹40 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | - | - | - | - | ₹2.81 Cr |
| Non Current Investments | - | - | ₹0.78 Cr | ₹0.78 Cr | ₹0.78 Cr |
| Long Term Investment | - | - | ₹0.78 Cr | ₹0.78 Cr | ₹0.78 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | ₹0.78 Cr | ₹0.78 Cr | ₹0.78 Cr |
| Long Term Loans & Advances | ₹14 Cr | ₹10 Cr | ₹5.95 Cr | ₹4.43 Cr | ₹4.31 Cr |
| Other Non Current Assets | ₹0.26 Cr | ₹0.06 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.95 Cr |
| Total Non-Current Assets | ₹103 Cr | ₹75 Cr | ₹70 Cr | ₹60 Cr | ₹49 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹60 Cr | ₹50 Cr | ₹31 Cr | ₹22 Cr | ₹16 Cr |
| Raw Materials | ₹15 Cr | ₹10 Cr | ₹7.98 Cr | ₹6.24 Cr | ₹3.64 Cr |
| Work-in Progress | ₹22 Cr | ₹21 Cr | ₹5.23 Cr | ₹2.67 Cr | ₹4.08 Cr |
| Finished Goods | ₹15 Cr | ₹11 Cr | ₹8.80 Cr | ₹6.64 Cr | ₹3.48 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | - | - | - | - | - |
| Other Inventory | ₹7.83 Cr | ₹7.44 Cr | ₹8.62 Cr | ₹6.94 Cr | ₹4.84 Cr |
| Sundry Debtors | ₹103 Cr | ₹79 Cr | ₹63 Cr | ₹45 Cr | ₹34 Cr |
| Debtors more than Six months | ₹25 Cr | ₹7.30 Cr | ₹7.19 Cr | ₹5.97 Cr | ₹4.01 Cr |
| Debtors Others | ₹77 Cr | ₹72 Cr | ₹56 Cr | ₹39 Cr | ₹30 Cr |
| Cash and Bank | ₹147 Cr | ₹29 Cr | ₹19 Cr | ₹17 Cr | ₹10 Cr |
| Cash in hand | ₹0.29 Cr | ₹0.40 Cr | ₹0.35 Cr | ₹0.39 Cr | ₹0.35 Cr |
| Balances at Bank | ₹147 Cr | ₹28 Cr | ₹19 Cr | ₹17 Cr | ₹10 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹1.70 Cr | ₹0.52 Cr | ₹0.91 Cr | ₹0.32 Cr | ₹5.25 Cr |
| Interest accrued on Investments | ₹0.50 Cr | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | ₹0.18 Cr | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹1.01 Cr | ₹0.52 Cr | ₹0.33 Cr | ₹0.31 Cr | ₹0.29 Cr |
| Other current_assets | - | - | ₹0.58 Cr | ₹0.01 Cr | ₹4.97 Cr |
| Short Term Loans and Advances | ₹31 Cr | ₹29 Cr | ₹21 Cr | ₹18 Cr | ₹5.73 Cr |
| Advances recoverable in cash or in kind | ₹9.31 Cr | ₹7.15 Cr | ₹6.09 Cr | ₹4.48 Cr | ₹2.42 Cr |
| Advance income tax and TDS | ₹11 Cr | ₹9.74 Cr | ₹6.70 Cr | ₹3.63 Cr | ₹1.73 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹11 Cr | ₹13 Cr | ₹8.17 Cr | ₹9.42 Cr | ₹1.58 Cr |
| Total Current Assets | ₹342 Cr | ₹188 Cr | ₹134 Cr | ₹103 Cr | ₹71 Cr |
| Net Current Assets (Including Current Investments) | ₹228 Cr | ₹93 Cr | ₹65 Cr | ₹48 Cr | ₹35 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹445 Cr | ₹262 Cr | ₹204 Cr | ₹163 Cr | ₹120 Cr |
| Contingent Liabilities | ₹1.73 Cr | ₹1.55 Cr | ₹1.51 Cr | ₹1.77 Cr | ₹1.59 Cr |
| Total Debt | ₹138 Cr | ₹15 Cr | ₹20 Cr | ₹21 Cr | ₹17 Cr |
| Book Value | 195.25 | 163.43 | 127.82 | 96.05 | 71.37 |
| Adjusted Book Value | 195.25 | 155.65 | 121.73 | 91.48 | 67.97 |
Compare Balance Sheet of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,390.3 Cr | -1.4% | 46.3% | 17.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -1.4% |
46.3% |
17.7% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses